OPGN OpGen Corp Company Cash Funds

OpGen Corp (OPGN) - corporate logo

OpGen, Inc. (OPGN) focuses on monetizing diagnostic platforms and expanding Acuitas test sales following a financial restructuring. The current cash position demonstrates liquidity, with the latest value recorded as 0.00. The company's technologies accelerate the discovery of antibiotics to combat hospital-acquired infections. However, capital shortages and protracted disputes with European subsidiaries create significant risks to the business's survival.

Company Total Cash Volume: OpGen Inc (OPGN) for 07/04/2022 - 08/31/2024

Summary analytical data breakdowns for OpGen Inc (OPGN)

- stock value and consensus price forecast:
Summary company analytics:OpGen, Inc. OPGN
Brand item of OpGen

When constructing a long-term portfolio, fundamental screening requires an assessment of liquidity relative to the asset's market value. This indicator compares net cash balances with market capitalization to identify the degree of undervaluation and bankruptcy risks. For OpGen, Inc. (OPGN), this is critical due to an acute shortage of funds and a management crisis. Analyzing the company's cash reserve volume on GURU.Markets allows for tracking management's ability to restructure its obligations.